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Nitrate (NO3) and nitrite (NO2) are known to be cardiopro-
tective and to alter energy metabolism in vivo. NO3 action
results from its conversion to NO2 by salivary bacteria, but the
mechanism(s) by which NO2 affects metabolism remains
obscure. NO2 may act by S-nitrosating protein thiols, thereby
altering protein activity. But how this occurs, and the functional
importance of S-nitrosation sites across the mammalian pro-
teome, remain largely uncharacterized. Here we analyzed
protein thiols within mouse hearts in vivo using quantitative
proteomics to determine S-nitrosation site occupancy. We
extended the thiol-redox proteomic technique, isotope-coded
affinity tag labeling, to quantify the extent of NO2-dependent
S-nitrosation of proteins thiols in vivo. Using this approach,
called SNOxICAT (S-nitrosothiol redox isotope-coded affinity
tag),we found that exposure toNO2undernormoxic conditions
or exposure to ischemia alone results in minimal S-nitrosation
of protein thiols. However, exposure to NO2 in conjunction
with ischemia led to extensive S-nitrosation of protein thiols
across all cellular compartments. Severalmitochondrial protein
thiols exposed to the mitochondrial matrix were selectively
S-nitrosated under these conditions, potentially contributing to
the beneficial effects ofNO2 onmitochondrialmetabolism.The
permeability of the mitochondrial inner membrane to HNO2,
but not to NO2, combined with the lack of S-nitrosation during
anoxia alone or by NO2 during normoxia places constraints on
how S-nitrosation occurs in vivo and on its mechanisms of car-
dioprotection andmodulation of energy metabolism. Quantify-
ing S-nitrosated protein thiols now allows determination of
modified cysteines across the proteome and identification of
those most likely responsible for the functional consequences
of NO2 exposure.
Until recently, nitrate (NO3) and nitrite (NO2) were consid-
ered biologically inert byproducts of NO metabolism in mam-
mals, but now it is clear that they impact significantly on mam-
malian physiology and energy metabolism (1). Dietary NO3 is
converted to NO2 by salivary bacteria (2), and this NO2 is
thought to account for most of the biological properties of
NO3 in mammals. For example, NO2 can act in vivo as a
cytoprotectant during cardiac ischemia–reperfusion injury
(3–5) and as a modulator of mitochondrial function (4) and
exercise efficiency (6). How NO2 exerts its effects in vivo is
unclear, but a major component seems to be the S-nitrosa-
tion (or S-nitrosylation) of cysteine residues on proteins (7)
(Fig. 1A). Protein cysteine S-nitrosation is a posttransla-
tional modification through which NO and its metabolites
exert some of their actions by reversibly altering protein
function (8–18). Therefore, a plausible mode of action of
NO2 in vivo is via protein S-nitrosation (Fig. 1A). This
notion is supported by a number of studies that have shown
that NO2 treatment in vivo broadly increases protein S-ni-
trosation (3–5).
Even so, the functional relevance of S-nitrosation by NO2 in
vivo remains uncertain. This is in part because the proteomic
methods used to identify the cysteine residues and proteins
affected by S-nitrosation (18–20) do not measure the extent of
cysteine modification. Quantification of the extent of protein
S-nitrosation on a particular cysteine residue (i.e. site occu-
pancy) is essential to identify the functional nodes through
which S-nitrosation may exert its physiological and pharmaco-
logical roles. Althoughmany cysteine residuesmay bemodified
indiscriminately to a low extent, these alterations are unlikely to
have major physiological consequences; instead, we expect
that only cysteine residues that are extensively modified by
NO2 can explain the biological actions of this signaling
modality (although we cannot exclude gain-of-function
effects). To address this unmet need, we adapted cysteine-
reactive isotope-coded affinity tag (ICAT)4 approaches (21),
which both identify and quantify the extent of reversible
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modification of a cysteine residue (22–25). To do this, we
modified sample processing so that, instead of identifying all
reversibly modified protein thiols, only S-nitrosated cys-
teines are analyzed and quantified. Application of this
approach, which we term SNOxICAT, allowed us to identify
cysteine residues that are S-nitrosated and, most impor-
tantly, quantify the extent of their S-nitrosation.
Here we have used SNOxICAT to study the impact of NO2
on themouse heart in vivo. The heart was chosen because of the
substantial interest in uncovering the mechanisms underlying
both the cytoprotective and othermetabolicmodulatory effects
of NO2 on cardiac function (1). Using this approach, we have
identified a range of protein thiols that were S-nitrosated by
NO2 in the heart and quantified the extent of thismodification.
Interestingly, the number of protein thiols in the heart substan-
tiallymodified byNO2was dramatically increased by ischemia,
suggesting that the combination of NO2 and ischemia is nec-
essary for extensive S-nitrosation in vivo. S-nitrosation was
not increased by NO2 during normoxia or by ischemia
alone. Furthermore, several protein thiols S-nitrosated by
NO2 during ischemia were on mitochondrial proteins, pro-
viding a potential mechanistic link to the effects of NO2 on
mitochondrial function.
Results and discussion
Using SNOxICAT to identify and quantify S-nitrosation of
cardiac proteins in vivo
In exploring how NO2 might lead to protein S-nitrosation,
and to infer proteins with potential physiological roles, we
wanted to identify the sites of S-nitrosation in vivo and also
quantify the extent of modification on individual targets. How-
ever, S-nitrosothiols are too unstable to survive analysis; hence,
they need to be measured indirectly. To do this, we extended
the redox-proteomic method OxICAT, which uses Cys-ICAT
chemistry to both quantify and identify thiols that are reversibly
oxidized, which has been applied to Escherichia coli (22), Sac-
charomyces cerevisiae (25), Caenorhabditis elegans (23), Dro-
sophila melanogaster (24), and to the mouse heart (26).
OxICAT identifies reversibly oxidized protein thiols, so we
refined OxICAT to develop the SNOxICAT approach, which
reports on S-nitrosated protein thiols (Fig. 1B). To do this, tis-
sue samples were rapidly stabilized by solubilization in TCA in
the presence of sulfanilamide (Fig. 1B), which both preserved
endogenous S-nitrosothiols and prevented artifactual S-nitro-
sation of free thiols by acidified NO2 during sample workup
(27) (Fig. 1B). Following stabilization, the sampleswere neutral-
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Figure 1. The SNOxICATmethodology. A, S-nitrosation of sensitive surface protein thiols. A small subset ofmitochondrial surface protein thiols are sensitive
to S-nitrosation, which is thought to occur by twomechanisms. The thiolate form of a sensitive thiol can react with a nitrosonium ion to form an S-nitrosothiol
(left). Alternatively, the thiyl radical form, generated by one electron oxidation of a thiol or thiolate,may react directly with NO to form an S-nitrosothiol (right).
The resulting reversible modification may have functional consequences for the target protein or, alternatively, could block other irreversible oxidative
modifications from occurring on the thiol. B, SNOxICAT methodology. Following in vivo interventions, mouse myocardial tissue is excised, and thiols are
stabilized by homogenization in 20% TCA containing 0.5% sulfanilamide. Unmodified protein thiols are labeled with C0-ICAT, and then S-nitrosated thiols are
chemically reduced and labeled with C9-ICAT, allowing for identification and quantification of the S-nitrosation status of protein thiols across the proteome.
The peptides are then isolated and analyzed by mass spectrometry. C, experimental design for comparative analysis of S-nitrosation status in the mouse
heart.
Measuring cardiac protein S-nitrosation
J. Biol. Chem. (2017) 292(35) 14486–14495 14487
ized, and unmodified cysteine residueswere labeledwith “light”
C0-ICAT (Fig. 1B), and then protein S-nitrosothiols were
labeled with “heavy” C9-ICAT after their selective reduction by
Cu(I) was achieved by adding low concentrations of ascorbic
acid andCuSO4 (Fig. 1B) (28, 29). Then the samplewas digested
with trypsin, and cysteine-containing peptides that had reacted
with C0-ICAT or C9-ICAT were enriched by affinity purifica-
tion using the biotin tag on the ICAT reagents, separated by
liquid chromatography, and analyzed by MS. As both the C0
andC9 ICAT labeled peptides are chemically identical and elute
at the same point after liquid chromatography, this enabled the
extent of modification of the cysteine residue of interest to
be quantified. In-line sequencing enabled the peptides and
their cognate proteins to be identified by MS-MS. Hence, we
could identify protein cysteine residues that were S-nitro-
sated in vivo and, at the same time, determine the extent of
this modification.
Quantitative MS-MS data obtained from this approach were
applied to several cardiac interventions in vivo (Fig. 1C). Data
from individual experiments were cross-referenced using an
HPLC-MS alignment algorithm to maximize peptide coverage
(30). This enabled both the identification and the quantification
of heavy and light ICAT signals for 2203 cysteine residues in the
myocardium that came from 721 proteins (supplemental Table
S1). These signals were converted to a percent S-nitrosation
value ((100 heavyICAT)/(heavyICAT lightICAT)) for each
particular cysteine residue (supplemental Table S2). From the
total pool of identified cysteine peptides with quantitative S-ni-
trosation data, between 1235 and 1868 were quantified at least
three times.One complicationwith quantifying S-nitrosation is
that many cysteines are not S-nitrosated at all; hence,55% of
residues only have one ICAT label. A failure to observe both
labels can occur because the residue is either not S-nitrosated
or is fully S-nitrosated; alternatively, it may occur for
technical reasons related to MS instrumentation and software.
Thus, although it is biologically important to include these 0
and 100% S-nitrosated values, a proportion of them are techni-
cal artifacts related to a failure in peak identification. To pro-
vide an accurate representation of in vivo S-nitrosation
required differentiation between these two scenarios. To do
this, we noted that a hallmark of informative data points is that
they should have similar S-nitrosation across biological repli-
cates and, thus, a low corresponding S.E. Conversely, apparent
S-nitrosation values arising because of technical artifacts are
unconstrained by the S-nitrosation of their biological replicates
and, thus, are likely to exhibit higher S.E. values. Thus, a further
curated dataset was generated where peptides with a highly
variable cysteine S-nitrosation state were assumed to arise
because of technical artifact and were excluded (see supple-
mental Fig. S1 and “Experimental procedures” for further dis-
cussion), leaving 866–1581 peptides (supplemental Table S3).
The total number of cysteine-containing peptides in an in silico
trypsin digest of the total mouse genome is 320,000; hence,
we observed about0.5% of the total number of cysteine resi-
dues present in the mouse genome.
We first used this approach to explore the baseline levels of
S-nitrosation in the normoxic heart (Fig. 2A and supplemental
Table S1). Under normoxic conditions, we found 907 cysteine
residues with some degree of sensitivity to copper/ascorbate,
consistent with S-nitrosation. This is in agreement with previ-
ous studies that have established widespread S-nitrosation
under baseline conditions in vivo (19). However, of all the cys-
teine residues identified, over half were less than 1% S-nitro-
sated (Fig. 2A), whereas only a small number (5%, n  72)
were greater than 50% S-nitrosated. Thus, under basal condi-
tions, there is low-level S-nitrosation of several protein thiols,
but very few cysteine residues are extensively modified, dem-
onstrating the importance of quantifying site occupancy.
We were particularly interested in assessing the degree of
protein S-nitrosation in mitochondria compared with the rest
of the cell. Therefore, we divided S-nitrosated proteins into
mitochondrial or non-mitochondrial (Fig. 2B) and then further
separated proteins that were S-nitrosated by greater than 50%
(Fig. 2C). These analyses showed that there was a slight dimin-
ishment in enrichment of S-nitrosation in mitochondrial pro-
teins under basal conditions.
Effect of NO2
 on protein S-nitrosation in the normoxic and
ischemic heart
To assess the effect of NO2 on protein thiols in the heart, we
injectedNaNO2 intravenously intomice at a concentration that
has been reported to protect the heart against ischemia–
reperfusion injury and drive S-nitrosation in the heart (4, 31)
(Fig. 1C). The S-nitrosation status of cysteine residues in the
heart of normoxic mice was largely unchanged by NO2 injec-
tion (Fig. 3A). As the extent of S-nitrosation by NO2 has been
shown to increase upon ischemia (4), we next set out to assess
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Figure 2. Quantification of basal S-nitrosation in the mouse heart by
SNOxICAT. A, overall detailed distribution of percentage S-nitrosation status
of protein thiols in the heart under baseline conditions. The percentage S-ni-
trosation status is distributed in 2% quantiles, indicating the proportion of
total cysteines identified exhibiting a particular level of S-nitrosation. The
inset shows an expansion of these findings. B and C, pie charts showing the
relative amount of mitochondrial and non-mitochondrial S-nitrosated cys-
teine residues in the myocardium under basal conditions for all S-nitrosated
proteins detected (B) and for proteins that were S-nitrosated by more than
50% (C).
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the effects of NO2 on cardiac S-nitrosation following exposure
to 25min of ischemia (Fig. 3A). Under these conditions, admin-
istration of NO2 led to a dramatic increase in overall S-nitro-
sation in the ischemic myocardium, although ischemia alone
did not increase S-nitrosation (Fig. 3A). These changes are
quantified in Fig. 3B as the means of the extent of S-nitrosation
of all the peptides. Together, the data in Fig. 3,A and B, suggest
that there was an increase in the average extent of S-nitrosation
when there was a combination of NO2 and ischemia but not
with either alone.
To test the effectiveness of the dataset curation and further
assess changes in S-nitrosation, we switched our focus from
aggregate levels of S-nitrosation under different conditions to
the S-nitrosation of individual cysteine residues. As there was
no apparent biological shift in S-nitrosation at the population
level in response to NO2 alone relative to the control, this pro-
vided an opportunity to test the validity of our curation
described previously. As expected, the raw and curated plots of
these two independently determined values coalesced around a
line of slope 1, with most values clustering near the origin
(supplemental Fig. S1, A and C). Furthermore, the shift in S-
nitrosation with NO2 and ischemia is readily apparent in both
the non-curated and curated datasets (supplemental Fig. S1, B
and D). The data points excluded from analysis show no such
correlation and lacked an excess of statistically interesting com-
parisons above the false discovery rate (supplemental Fig. S1, E
and F). Together, this argues that our curation is appropriate
and effective. Next, we compared how the extent of S-nitrosa-
tion of individual peptides is altered under different conditions.
Volcano plots were created to assess changes in S-nitrosation
on individual peptides in response to NO2 alone, ischemia
alone, and ischemia  NO2, all relative to control conditions.
There was a clear bias toward peptides being significantly S-ni-
trosated by ischemiaNO2 (Fig. 4A). Thiswas not observed in
the symmetrical plots for NO2 (Fig. 4B) or ischemia alone (Fig.
4C). This is illustrated further in Fig. 4D, which examines the
increase in S-nitrosation on individual peptides. Along the x
axis, we plotted the increase in S-nitrosation on peptides when
tissue exposed to NO2 and ischemia is compared with nor-
moxic tissue exposed to NO2. Along the y axis, we plotted the
increase in S-nitrosation on peptides when tissue exposed to
NO2 and ischemia is compared with ischemic tissue. The
majority of peptides (82%) appear in the top right quadrantwith
a slope of1, consistent with S-nitrosation being a process that
depends on both ischemia and NO2. Of the 1081 cysteines
present in both control tissue and that exposed to NO2 and
ischemia, statistical comparisons could be made for 644, and of
these, 264 were significantly changed (p  0.05). This is an
excess of 232 over the false discovery rate of 32 (supplemental
Fig. S1D). After Benjamini-Hochberg correction for multiple
comparisons, 102 cysteine residues could be identified as
changing in response to NO2 and ischemia (supplemental
Table S4). However, although there is a statistically significant
shift in the S-nitrosation status of a large number of peptides
with ischemia  NO2, many cysteines are not S-nitrosated at
all in the control heart and are consequently lost from statistical
comparisons. Consequently, we have focused on large absolute
shifts in S-nitrosation, as these are most likely to contribute to
biologically meaningful changes to protein function within the
tissue. Supplemental Table S4 shows the 163 sites where NO2
in the ischemic myocardium increases S-nitrosation by more
than 10 percentage points above conditions of normoxia, NO2
alone, or ischemia alone.
Thus, we conclude that there is a substantial population of
protein cysteines that become selectively S-nitrosated by NO2
in the ischemic heart but that are unmodified by NO2 under
normoxic conditions or by ischemia alone. This is in agreement
with previous studies that show that overall levels of S-nitroso-
thiols increase following NO2 administration under ischemic
conditions (32).
S-nitrosation ofmitochondrial oxidoreductases by NO2

during ischemia
NO2 has a number of effects on mitochondrial metabolism,
and several of the most substantially modified targets of S-ni-
trosation were mitochondrial. To further examine the selective
quantitative effects of S-nitrosation by NO2 in the ischemic
heart, we clustered proteins with cysteine thiols exhibiting a
differential S-nitrosation status (defined as 10 percentage
points between conditions) using gene ontology term enrich-
ment, with the total identified population of cysteine thiol con-
taining proteins as the reference background. This approach
identified S-nitrosation targets specific to each intervention
that clustered in specific cellular pathways (Fig. 5A and supple-
mental Table S5). Among themost prevalent targets selectively
modified by ischemic NO2 were mitochondrial oxidoreducta-
ses involved in redox metabolism, electron transport, and the
mitochondrial tricarboxylic acid cycle pathways (Fig. 5A and
supplemental Table S5). Interestingly, despite this selective
S-nitrosation of mitochondrial oxidoreductases, the average
extent of S-nitrosation of all mitochondrial peptides (Fig. 5B)
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Figure 3. Effect of NO2
 on the S-nitrosothiol proteome in the mouse
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was similar to that observed for non-mitochondrial peptides
(Fig. 5C). This suggests that mitochondrial oxidoreductases
may be selective targets for modification even when compared
with other mitochondrial proteins. Indeed, many of the path-
ways identified as enriched targets in the ischemic NO2 treat-
ments are present in the mitochondrial matrix, as opposed to
mitochondrial protein thiols that face the intermembrane
space or are located on the outer membrane. The mitochon-
drial matrix is a distinct compartment from the rest of the cell,
with an environment thatmay impact NO2metabolism during
ischemia. To get a clearer picture of whether S-nitrosation was
occurring in the mitochondrial matrix in response to exoge-
nous NO2, we limited the analysis to soluble enzymes from the
TCA cycle, which are all present in the mitochondrial matrix
(supplemental Table S3). When this was done, there was again
a clear increase in S-nitrosation within the mitochondrial
matrix in response to NO2 and ischemia (Fig. 5D). Thus, the
combination of NO2 and ischemia leads to a clear increase in
S-nitrosation within the mitochondrial matrix, although how
this takes place is not known.
To explore how the combination ofNO2 and ischemiamight
impact the mitochondrial matrix, we examined whether NO2
itself could gain access to the mitochondrial matrix. When
mitochondria were incubated in a high concentration of KNO3,
the organelles did not swell until theK ionophore valinomycin
was added to enable K entry along with NO3. Valinomycin
allows for net uptake of KNO3 and, thereby, leads to swelling,
consistent with the mitochondrial inner membrane being per-
meable to NO3 (Fig. 5E). In contrast, when mitochondria were
incubated in KNO2, addition of valinomycin did not lead to
swelling (Fig. 5E), suggesting that the mitochondrial inner
membrane is not permeable to NO2 per se. However, when
NO2 uptake was examined in the presence of valinomycin,
along with the uncoupler carbonyl cyanide p-trifluorome-
thoxyphenylhydrazone (FCCP) to render the inner membrane
permeable to protons, it did lead tomitochondrial swelling (Fig.
5E). This indicates that, in vivo, NO2 itself is unlikely to enter
mitochondria but that its conjugate acid HNO2 (pKa  3.16)
can. Therefore, one possibility is that, in vivo during ischemia,
NO2 leads to mitochondrial protein S-nitrosation by generat-
ing membrane-permeant HNO2 that can diffuse into the
matrix. This membrane permeability may be further enhanced
by the acidic environment likely to be present in ischemic tissue
and could contribute to the increase in S-nitrosation observed
with NO2 and ischemia relative to NO2 alone. However, the
mechanism bywhichNO2 leads to S-nitrosation is unclear and
may require the further reaction of HNO2 to potential S-nitro-
sating species such as N2O3 or catalysis by metalloenzymes.
To further explore how ischemic exposure to NO2 might
affectmitochondrial oxidoreductase function,we examined the
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localization of substantially S-nitrosated sites on these mito-
chondrial pathways. We focused specifically on mitochondrial
oxidoreductase sites that were identified as a cluster that is
selectivelymodified by ischemicNO2 (supplemental Table S5).
Within this cluster, we found 22 sites that mapped to subunits
of the OXPHOS machinery (Fig. 6A) and many in regions that
have been implicated in regulating oxidative metabolism. For
example, complex IV is S-nitrosated on cysteine residues 112 or
115 (Fig. 6B), which co-ordinate Zn2 binding and have been
suggested to regulate aspects of complex function (33). Com-
plex III is modified on cysteine residue 139 of subunit IV (Fig.
6C), proximal to the cytochrome c reduction site, whereas both
the electron-transferring flavoprotein (Fig. 6D) and succinate
dehydrogenase (Fig. 6E) are modified at locations proximal to
their flavin oxidation sites. The OXPHOS complex containing
the most ischemic S-nitrosation sites (8) was complex I, most
notably on four cysteine residues on the NDUFV1 subunit con-
taining the flavin mononucleotide that is the proximal elec-
tron acceptor from NADH (Fig. 6, F–H). In addition, there
was substantial S-nitrosation on the ND3 subunit at cysteine
39, which is close to the ubiquinone binding site, and its
S-nitrosation is established to inhibit complex I in the ischemic
myocardium (16). Substantial S-nitrosation of cysteine residues
on NDUFA10 and NDUFA11 was also observed (Fig. 6G).
NDUFA11 contributes the contact points between complex I
and complex III (34, 35), and the two cysteines may form two
disulfides with a further two cysteines on NDUFA11 that were
on peptides not observed by SNOxICAT.
In addition to ischemic NO2 modifications that cluster to
functional domains of OXPHOS complexes, it is noteworthy
that, under basal conditions, substantial copper/ascorbate-sen-
sitive modification was observed on conserved cysteine resi-
dues on two isoforms of the ADP/ATP carrier (AAC1 and
AAC2). Both exhibited substantial copper/ascorbate-sensitive
modification of cysteine 257 during normoxia (Fig. 6I), despite
the two peptides containing cysteine 257 differing in sequence
and, consequently, mass. Under basal conditions, this site was
among the most substantially modified sites observed (60–
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Figure 5. Intracellular localization of S-nitrosated protein thiols upon NO2
 and ischemia. A, pathway analysis of proteins containing cysteine residues
sensitive to selective S-nitrosation (10 percentage point average shift in S-nitrosation) in each treatment protocol, indicating the number of significantly
enriched pathways. B and C, subcellular localization of cysteines selectively targeted for S-nitrosation by NO2
 under ischemic conditions.D, TCA cycle targets
of S-nitrosation. E, NO2
 uptake assessed by swelling of mitochondria. Mitochondria (0.5 mg protein/ml) were incubated in 10 mM Tris-HCl (pH 7.2) at 37 °C
supplementedwith rotenone (4g/ml) and containing either KNO2 or KNO3 (100mM). Absorbance wasmeasured at 550 nm, and valinomycin (1M) or FCCP
(2 M) was added where indicated. Shown is a typical result of three replicates. **, p 0.01; ****, p 0.001.
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100% S-nitrosated). The nature of this modification is unclear,
as it was largely unmodified under ischemic conditions. This
site may be of particular interest, as chemical modification of
this cysteine residue has been shown to have substantial effects
onAACprotein activity (36). Furthermore, chemical and redox
modifications of carrier proteins at this conserved cysteine site
have been shown to affect carrier function and mitochondrial
metabolism (37–39).
Conclusions
The mechanism by which NO2 modulates cardiac function
in vivo is not clear. To address this, we applied ICAT labeling
methods (22, 24) to identify and quantify S-nitrosation occu-
pancy of protein cysteine residues across the proteome. Appli-
cation of this approach, which we term SNOxICAT, allowed us
to identify and quantify the targets of S-nitrosation by NO2 in
the heart in vivo for the first time.
Interestingly, only during ischemia were targets modified in
the heart by NO2. This suggests that the conditions during
ischemia enhance protein S-nitrosation and that oxygen and/or
pH are an important constraint on how NO2 interacts with
metabolism. S-nitrosation was not confined to a particular cel-
lular compartment and was distributed throughout the tissue.
The NO2 anion itself is membrane-impermeant and so does
not entermitochondria, suggesting that ischemic NO2 leads to
mitochondrial S-nitrosation because of the membrane perme-
ation of its conjugate acid HNO2. Quantitative assessment of
themitochondrial targets of S-nitrosation revealed a number of
interesting candidates for further studies to assess the func-
tional consequences of these modifications and provide an
important starting point to further assess how NO2 exerts its
effects on mitochondrial function. In summary, we have devel-
oped a new technical approach that provides important new
information on how NO2 and NO2 may have their beneficial
effects in vivo.
Experimental procedures
Mouse experiments
For in vivo heart procedures, an open-chest, in situ heart
model was used as described previously (40). Briefly, male
C57BL/6 mice (8–10 weeks old, Charles River Laboratories)
were anesthetized with sodium pentobarbital (70 mg/kg intra-
peritoneally), intubated endotracheally, and ventilated at 110
breaths/min with a tidal volume between 125 and 150 ml. A
thoracotomy was performed, and a prominent branch of the
left anterior descending coronary artery was surrounded by a
7-0 Prolene suture that was passed through a small plastic tube.
Ischemiawas induced by tightening the tubing against the heart
surface. Mice were divided into four groups: normoxia (sham
operation in which the suture was placed but the left anterior
descending coronary artery was not occluded), normoxia 10
mg/kg systemic intravenous sodiumnitrite, 30min of ischemia,
and 30 min of ischemia  10 mg/kg systemic intravenous
sodium nitrite administered at 25 min of ischemia (31).
Cys-ICAT labeling of heart tissue
At all times during S-nitrosothiol derivatization, samples
were shielded from light. Following in vivo interventions, heart
tissue was rapidly excised and immediately homogenized in
ice-cold 20% TCA containing 0.5% sulfanilamide. The homo-
genate was incubated on ice for 30min and then pelleted for 30
min at 16,000 g at 4 °C. The pellet was washed with 10% and
5% (w/v) TCA and then resuspended in 80 l of denaturing
alkylating buffer (6 M urea, 2% (w/v) SDS, 200 mM Tris-HCl, 10
mM EDTA, 100 M diethylenetriamine pentaacetate (DTPA),
and 10 M neocuproine). The contents of one vial of cysteine-
reactive cleavable ICAT reagent (AB SCIEX) was added to each
biological replicate sample to label reduced cysteine residues at
37 °C andmixed at 1400 rpm for 2 h on an Eppendorf Thermo-
mixer. Sample protein was precipitated with 20% TCA, incu-
bated at 4 °C for 30 min, and pelleted at 4 °C and 16,000 g for
30 min. The pellet was washed twice as above and then resolu-
bilized in 100 l of denaturing alkylating buffer containing 10
MCuSO4 and 1mM ascorbic acid to reduce protein S-nitroso-
thiols in the presence of a second isotopically heavy, cysteine-
reactive, cleavable ICAT reagent. Proteins were incubated at
37 °C and mixed at 1400 rpm for 2 h. The amount of protein to
be processed was optimized to ensure saturation of thiol label-
ing by the ICAT reagent according to the instructions of the
manufacturer. The sample was precipitated with 5 volumes of
ice-cold acetone, stored at20 °C for 2 h, and pelleted at 4 °C at
16,000  g for 30 min. The pellet was washed twice with 90%
ice-cold acetone and resuspended in denaturing buffer, and
then 1 volume of trypsin (AB SCIEX, resuspended in H2O) was
added (both provided by the ICAT kit). Proteins were digested
at 37 °C with mixing at 1400 rpm overnight. Digested peptides
were enriched for cysteine-containing peptides first on a cation
exchange cartridge and then on an avidin affinity cartridge (AB
SCIEX) as described previously (24). Eluted cysteine-contain-
ing, ICAT-labeled peptides were dried down overnight in a
SpeedVac, and the biotinmoiety of the ICAT labelwas removed
by incubation with the cleaving reagents provided in the ICAT
kit for 2 h at 37 °C with mixing at 1400 rpm). The isolated
peptides were then dried down in a SpeedVac for MS analysis.
LC/MS-MS analysis of peptides and data analysis
The LC/MS-MS analysis of the SNOxICAT-labeled peptides
was carried out using anOrbitrap LTQXL (Thermo Scientific),
where peptideswere analyzed after chromatography on a nano-
scale reverse-phase column (75-m inner diameter, 100-mm
Figure 6. Identification ofmitochondrial protein cysteine and pathway targets of S-nitrosation caused by ischemic NO2
. A, structures of OXPHOS enzymes,
with subunits containing targets of ischemic S-nitrosation by NO2
 highlighted in red and the number of S-nitrosated cysteine residues given in parentheses. B–E,
quantificationof the S-nitrosation status of cysteine residues that are selectivelymodifiedbyNO2
during ischemiaon complex IV (B), complex III (C), electron transfer
flavoprotein (D, ETF), and succinatedehydrogenase (E, SDH). Structures are alsoprovided for target subunits containing flavin cofactors, indicating the locationof the
flavin (yellow) and relevant cysteine residues. F, structureofmitochondrial complex I, indicating subunits containingcysteine residues that are selectivelymodifiedby
NO2
 during ischemia highlighted in red and the number of S-nitrosated cysteine residues given in parentheses.G, quantification of S-nitrosation status of complex I
cysteine residues sensitive tomodification by ischemic NO2
.H, structures of the flavin-containing NDUFV1 subunit, indicating the location of the flavin (yellow) and
relevant cysteine residues. I, modification of the S-nitrosation status of cysteine residue 257 onAAC1 andAAC2 under different conditions.
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length) with a gradient of 0–40% buffer B (95% acetonitrile and
0.1% formic acid) in buffer A (5% acetonitrile and 0.1% formic
acid) over 84min at 300 nl/min. Four biological replicates were
processed for each experiment. Peptides were identified using
Proteome Discoverer (Thermo Scientific) and the Mascot pro-
tein identification program (Matrix Science). All experiments
used the Mouse UniProt database (2013_12). Searches were
performedusing a 5-ppmprecursor ion tolerance, requiring the
N/C terminus of each peptide to have trypsin protease specific-
ity and allowing up to two missed cleavages. ICAT tags on cys-
teine residues (227.13 and236.16 Da) and methionine oxi-
dation (15.99 Da) were set as variable modifications. Because
many peptides were not observed in all replicates, the raw files
were then analyzed using MassChroQ software, which quanti-
fies peaks lacking MS2 sequence information by aligning them
using the retention time of peptides common to runs for which
MS2 information was obtained (30). An in silico tryptic digest
of the complete mouse proteome was performed using a mod-
ified proteogest script generating a file that listed all cysteine-
containing tryptic peptides with none, one, or two missed
cleavages, the cysteine residue number, and the Uniprot acces-
sion number of the protein (41). The proteogest script modifi-
cation was done by Dr. Alan Robinson (Medical Research
Council Mitochondrial Biology Unit). The peptide list gener-
ated by proteogest was used together with the output from
MassChroQ to sum the intensity from all peptide peak signals
containing the cysteine residue of interest (i.e. miss-cleaved,
methionine oxidation, different z values) and give a combined
signal for both the heavy and light forms of the peptide. A sig-
nificant complication with quantifying S-nitrosation compared
with general oxidation is that many cysteines are not S-nitro-
sated at all, and consequently, in this study under control con-
ditions,55% of residues in a particular replicate have only one
ICAT label. A failure to observe both labels can also occur for
technical reasons related to MS instrumentation and software,
or it can arise because the residue is either not S-nitrosated at all
or it is completely S-nitrosated. The simplest mechanism for
resolving this is to discard all peptides that lack both peaks, but
excluding 55% of the dataset would give a misleading picture of
in vivo S-nitrosation. Conversely, treating a failure of the instru-
mentation and software to find the correct peak as a biological
result is also misleading.
To differentiate between these two situations and provide a
more accurate representation of in vivo S-nitrosation, we uti-
lized the expected similarity of informative data points across
the four biological replicates. All data points with an S.E. of less
than 6were considered informative and automatically included
in the subsequent analyses, comprising 78% of the total. For
data points with an S.E. 6, heavy and light ICAT signals were
separately cross-referenced to the median heavy or light inten-
sity of that cysteine in the four biological replicates. Those with
an intensity signal20% of the heavy or light median intensity
were excluded. This step prevents a single technical failure with
either a heavy or light peak in one replicate, causing a group of
four replicates to be eliminated from analysis. This was neces-
sary, as only 387 cysteine residues (20%) were sufficiently
S-nitrosated to be observed with both heavy and light isotope
labels. Finally, all data points that still had an S.E. 8 or n 3
were excluded. S-nitrosation is presented as the percentage
(100 HeavyICAT) / (HeavyICAT LightICAT).
Information on the subcellular localization of the proteins
identified and the biological processes they participated in was
obtained using MitoMiner (http://mitominer.mrc-mbu.cam.
ac.uk/)5 (42). For bar charts, the data for distribution of propor-
tion of cysteine residues against percentage S-nitrosation were
generated by counting the number of cysteine residues in each
2% quantile for each individual biological replicate and then
averaging the relative values for each quantile over the four
biological replicates. For volcano plots of the extent of S-nitro-
sation of a given cysteine under one condition against its S-ni-
trosation under another condition, the significance of the shift
in S-nitrosation was assessed by an F test for variance followed
by the appropriate two-tailed Student’s t test, assuming equal or
unequal variance as appropriate. A Benjamini-Hochberg pro-
cedure was used to correct for multiple comparisons and thus
determine significant changes.
Mitochondrial experiments
Liver mitochondria were prepared from female Wistar rats
killed by stunning and cervical dislocation, followed by homog-
enization of the liver and differential centrifugation in ice-cold
STE buffer (250 mM sucrose, 10 mM Tris, and 1 mM EGTA (pH
7.4)). The protein concentration was determined by the biuret
assay using bovine serum albumin as a standard. For swelling
experiments, mitochondria (0.5 mg protein/ml) were incu-
bated in 10 mM TrisHCl (pH 7.2) at 37 °C supplemented with
rotenone (4 g/ml) and containing either KNO2 or KNO3 (100
mM). Absorbance was measured at 550 nm, and valinomycin (1
M) or FCCP (2 M) was added where indicated. Fig. 5E shows
a typical result of three replicates.
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